United States Stem Cell UCB Market Report 2017

January 2017 | 109 pages | ID: U7C096BFB72EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Stem Cell UCB

Revenue, means the sales value of Stem Cell UCB

This report studies sales (consumption) of Stem Cell UCB in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Caladrius Biosciences?
• Celgene?
• Mesoblast?
• Pluristem Therapeutics
• Athersys
• CHA Bio & Diostech?
• Cytori Therapeutics
• Nuo Therapeutics?
• Ocata Therapeutics?
• Opexa Therapeutics?
• Osiris Therapeutics?
• Teva Pharmaceuticals?
• United Therapeutics?

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Public cord blood banks
• Private cord blood banks
• Public Vs. Private UCB banks

Split by applications, this report focuses on sales, market share and growth rate of Stem Cell UCB in each application, can be divided into

• Therapeutics service companies
• Private and government research institutes
• Academic Institutes
• Research based pharmaceutical companies
• Public and Private cord blood banks

Contents

United States Stem Cell UCB Market Report 2017

1 STEM CELL UCB OVERVIEW

1.1 Product Overview and Scope of Stem Cell UCB
1.2 Classification of Stem Cell UCB
  1.2.1 Public cord blood banks
  1.2.2 Private cord blood banks
  1.2.3 Public Vs. Private UCB banks
1.3 Application of Stem Cell UCB
  1.3.1 Therapeutics service companies
  1.3.2 Private and government research institutes
  1.3.3 Academic Institutes
  1.3.4 Research based pharmaceutical companies
  1.3.5 Public and Private cord blood banks
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Stem Cell UCB (2011-2021)
  1.4.1 United States Stem Cell UCB Sales and Growth Rate (2011-2021)
  1.4.2 United States Stem Cell UCB Revenue and Growth Rate (2011-2021)

2 UNITED STATES STEM CELL UCB COMPETITION BY MANUFACTURERS

2.1 United States Stem Cell UCB Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Stem Cell UCB Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Stem Cell UCB Average Price by Manufactures (2015 and 2016)
2.4 Stem Cell UCB Market Competitive Situation and Trends
  2.4.1 Stem Cell UCB Market Concentration Rate
  2.4.2 Stem Cell UCB Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES STEM CELL UCB SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Stem Cell UCB Sales and Market Share by States (2011-2016)
3.2 United States Stem Cell UCB Revenue and Market Share by States (2011-2016)
3.3 United States Stem Cell UCB Price by States (2011-2016)

4 UNITED STATES STEM CELL UCB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Stem Cell UCB Sales and Market Share by Type (2011-2016)
4.2 United States Stem Cell UCB Revenue and Market Share by Type (2011-2016)
4.3 United States Stem Cell UCB Price by Type (2011-2016)
4.4 United States Stem Cell UCB Sales Growth Rate by Type (2011-2016)

5 UNITED STATES STEM CELL UCB SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Stem Cell UCB Sales and Market Share by Application (2011-2016)
5.2 United States Stem Cell UCB Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES STEM CELL UCB MANUFACTURERS PROFILES/ANALYSIS

6.1 Caladrius Biosciences?
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Stem Cell UCB Product Type, Application and Specification
    6.1.2.1 Public cord blood banks
    6.1.2.2 Private cord blood banks
  6.1.3 Caladrius Biosciences? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Celgene?
  6.2.2 Stem Cell UCB Product Type, Application and Specification
    6.2.2.1 Public cord blood banks
    6.2.2.2 Private cord blood banks
  6.2.3 Celgene? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Mesoblast?
  6.3.2 Stem Cell UCB Product Type, Application and Specification
    6.3.2.1 Public cord blood banks
    6.3.2.2 Private cord blood banks
  6.3.3 Mesoblast? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Pluristem Therapeutics
  6.4.2 Stem Cell UCB Product Type, Application and Specification
    6.4.2.1 Public cord blood banks
    6.4.2.2 Private cord blood banks
  6.4.3 Pluristem Therapeutics Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Athersys
  6.5.2 Stem Cell UCB Product Type, Application and Specification
    6.5.2.1 Public cord blood banks
    6.5.2.2 Private cord blood banks
  6.5.3 Athersys Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 CHA Bio & Diostech?
  6.6.2 Stem Cell UCB Product Type, Application and Specification
    6.6.2.1 Public cord blood banks
    6.6.2.2 Private cord blood banks
  6.6.3 CHA Bio & Diostech? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Cytori Therapeutics
  6.7.2 Stem Cell UCB Product Type, Application and Specification
    6.7.2.1 Public cord blood banks
    6.7.2.2 Private cord blood banks
  6.7.3 Cytori Therapeutics Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview
6.8 Nuo Therapeutics?
  6.8.2 Stem Cell UCB Product Type, Application and Specification
    6.8.2.1 Public cord blood banks
    6.8.2.2 Private cord blood banks
  6.8.3 Nuo Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.8.4 Main Business/Business Overview
6.9 Ocata Therapeutics?
  6.9.2 Stem Cell UCB Product Type, Application and Specification
    6.9.2.1 Public cord blood banks
    6.9.2.2 Private cord blood banks
  6.9.3 Ocata Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.9.4 Main Business/Business Overview
6.10 Opexa Therapeutics?
  6.10.2 Stem Cell UCB Product Type, Application and Specification
    6.10.2.1 Public cord blood banks
    6.10.2.2 Private cord blood banks
  6.10.3 Opexa Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
  6.10.4 Main Business/Business Overview
6.11 Osiris Therapeutics?
6.12 Teva Pharmaceuticals?
6.13 United Therapeutics?

7 STEM CELL UCB MANUFACTURING COST ANALYSIS

7.1 Stem Cell UCB Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Stem Cell UCB

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Stem Cell UCB Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Stem Cell UCB Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES STEM CELL UCB MARKET FORECAST (2016-2021)

11.1 United States Stem Cell UCB Sales, Revenue Forecast (2016-2021)
11.2 United States Stem Cell UCB Sales Forecast by Type (2016-2021)
11.3 United States Stem Cell UCB Sales Forecast by Application (2016-2021)
11.4 Stem Cell UCB Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Stem Cell UCB
Table Classification of Stem Cell UCB
Figure United States Sales Market Share of Stem Cell UCB by Type in 2015
Figure Public cord blood banks Picture
Figure Private cord blood banks Picture
Figure Public Vs. Private UCB banks Picture
Table Application of Stem Cell UCB
Figure United States Sales Market Share of Stem Cell UCB by Application in 2015
Figure Therapeutics service companies Examples
Figure Private and government research institutes Examples
Figure Academic Institutes Examples
Figure Research based pharmaceutical companies Examples
Figure Public and Private cord blood banks Examples
Figure United States Stem Cell UCB Sales and Growth Rate (2011-2021)
Figure United States Stem Cell UCB Revenue and Growth Rate (2011-2021)
Table United States Stem Cell UCB Sales of Key Manufacturers (2015 and 2016)
Table United States Stem Cell UCB Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Stem Cell UCB Sales Share by Manufacturers
Figure 2016 Stem Cell UCB Sales Share by Manufacturers
Table United States Stem Cell UCB Revenue by Manufacturers (2015 and 2016)
Table United States Stem Cell UCB Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Stem Cell UCB Revenue Share by Manufacturers
Table 2016 United States Stem Cell UCB Revenue Share by Manufacturers
Table United States Market Stem Cell UCB Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Stem Cell UCB Average Price of Key Manufacturers in 2015
Figure Stem Cell UCB Market Share of Top 3 Manufacturers
Figure Stem Cell UCB Market Share of Top 5 Manufacturers
Table United States Stem Cell UCB Sales by States (2011-2016)
Table United States Stem Cell UCB Sales Share by States (2011-2016)
Figure United States Stem Cell UCB Sales Market Share by States in 2015
Table United States Stem Cell UCB Revenue and Market Share by States (2011-2016)
Table United States Stem Cell UCB Revenue Share by States (2011-2016)
Figure Revenue Market Share of Stem Cell UCB by States (2011-2016)
Table United States Stem Cell UCB Price by States (2011-2016)
Table United States Stem Cell UCB Sales by Type (2011-2016)
Table United States Stem Cell UCB Sales Share by Type (2011-2016)
Figure United States Stem Cell UCB Sales Market Share by Type in 2015
Table United States Stem Cell UCB Revenue and Market Share by Type (2011-2016)
Table United States Stem Cell UCB Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Stem Cell UCB by Type (2011-2016)
Table United States Stem Cell UCB Price by Type (2011-2016)
Figure United States Stem Cell UCB Sales Growth Rate by Type (2011-2016)
Table United States Stem Cell UCB Sales by Application (2011-2016)
Table United States Stem Cell UCB Sales Market Share by Application (2011-2016)
Figure United States Stem Cell UCB Sales Market Share by Application in 2015
Table United States Stem Cell UCB Sales Growth Rate by Application (2011-2016)
Figure United States Stem Cell UCB Sales Growth Rate by Application (2011-2016)
Table Caladrius Biosciences? Basic Information List
Table Caladrius Biosciences? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Caladrius Biosciences? Stem Cell UCB Sales Market Share (2011-2016)
Table Celgene? Basic Information List
Table Celgene? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene? Stem Cell UCB Sales Market Share (2011-2016)
Table Mesoblast? Basic Information List
Table Mesoblast? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mesoblast? Stem Cell UCB Sales Market Share (2011-2016)
Table Pluristem Therapeutics Basic Information List
Table Pluristem Therapeutics Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pluristem Therapeutics Stem Cell UCB Sales Market Share (2011-2016)
Table Athersys Basic Information List
Table Athersys Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table Athersys Stem Cell UCB Sales Market Share (2011-2016)
Table CHA Bio & Diostech? Basic Information List
Table CHA Bio & Diostech? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table CHA Bio & Diostech? Stem Cell UCB Sales Market Share (2011-2016)
Table Cytori Therapeutics Basic Information List
Table Cytori Therapeutics Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytori Therapeutics Stem Cell UCB Sales Market Share (2011-2016)
Table Nuo Therapeutics? Basic Information List
Table Nuo Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nuo Therapeutics? Stem Cell UCB Sales Market Share (2011-2016)
Table Ocata Therapeutics? Basic Information List
Table Ocata Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ocata Therapeutics? Stem Cell UCB Sales Market Share (2011-2016)
Table Opexa Therapeutics? Basic Information List
Table Opexa Therapeutics? Stem Cell UCB Sales, Revenue, Price and Gross Margin (2011-2016)
Table Opexa Therapeutics? Stem Cell UCB Sales Market Share (2011-2016)
Table Osiris Therapeutics? Basic Information List
Table Teva Pharmaceuticals? Basic Information List
Table United Therapeutics? Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Stem Cell UCB
Figure Manufacturing Process Analysis of Stem Cell UCB
Figure Stem Cell UCB Industrial Chain Analysis
Table Raw Materials Sources of Stem Cell UCB Major Manufacturers in 2015
Table Major Buyers of Stem Cell UCB
Table Distributors/Traders List
Figure United States Stem Cell UCB Production and Growth Rate Forecast (2016-2021)
Figure United States Stem Cell UCB Revenue and Growth Rate Forecast (2016-2021)
Table United States Stem Cell UCB Production Forecast by Type (2016-2021)
Table United States Stem Cell UCB Consumption Forecast by Application (2016-2021)
Table United States Stem Cell UCB Sales Forecast by States (2016-2021)
Table United States Stem Cell UCB Sales Share Forecast by States (2016-2021)